Pathogenesis of Thymolipoma : Report of Three Cases
スポンサーリンク
概要
- 論文の詳細を見る
- 1995-01-01
著者
-
TOYAMA Tatsuya
Second Department of Surgery and Nagoya City University Medical School
-
Mizuno T
Second Department Of Surgery Nagoya City University Medical School
-
MASAOKA Akira
Second Department of Surgery, Nagoya City University Medical School
-
Toyama Tatsuya
Second Department Of Surgery Nagoya City University Medical School
-
MIZUNO TSUTOMU
Second Department of Surgery, Nagoya City University Medical School
-
SHIBATA KAZUO
Second Department of Surgery, Nagoya City University Medical School
-
YAMAKAWA YOUSUKE
Second Department of Surgery, Nagoya City University Medical School
-
NIWA HIROSHI
Second Department of Surgery, Nagoya City University Medical School
-
TORII KEI
Second Department of Surgery, Nagoya City University Medical School
-
Torii Kei
Second Department Of Surgery Nagoya City University Medical School
-
Masaoka A
Second Department Of Surgery Nagoya City University Medical School
-
Masaoka Akira
The Second Department Of Surgery Nagoya City University Medical School.
-
Masaoka Akira
Second Department Of Surgery Nagoya City University Medical School
-
Yamakawa Yosuke
Department Of Surgery Ii Nagoya City University Medical School
-
Shibata Kazuo
Second Department Of Surgery Nagoya City University Medical School
関連論文
- The Clinical Value of Microsatellite Instability and a Loss in Heterozygosity in Sporadic Breast Cancers
- Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer
- Hrad17 Expression in Thymoma
- Multicystic Mesothelial Cyst of the Mediastinum : Report of a Case
- Flow-Cytometric Diagnosis of Thymoma Using Needle Biopsy Specimens
- Thymidylate Synthase and Dihydropyrimidine Dehydrogenase mRNA Levels in Thymoma
- Ets-1 Gene Expression in Patients With Thymoma
- Ratio of Expression of p16^ to p14^ Correlates with the Progression of Non-small Cell Lung Cancer
- Elevated Serum Pro-MMP2 Levels in Patients with Stage IV Thymoma
- Elevated Serum Pro-MMP2 Levels in Patients with Advanced Lung Cancer Are Not Suitable as a Prognostic Marker